Show simple item record

dc.contributor.authorSargin, M.
dc.contributor.authorOguzhan, B.
dc.contributor.authorOlmez, B.
dc.contributor.authorKaradeniz, S.
dc.contributor.authorYilmaz, T.
dc.date.accessioned2021-03-03T19:35:17Z
dc.date.available2021-03-03T19:35:17Z
dc.identifier.citationYilmaz T., Sargin M., Olmez B., Karadeniz S., Oguzhan B., "Which of the criteria is more accurate ADA(IFG100) or IDF(IFG110) for the prediction of IGT 1 and IGT2 at high risk group? The RISK Study Results III", 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, Hollanda, 18 - 21 Eylül 2007, cilt.50
dc.identifier.othervv_1032021
dc.identifier.otherav_55632b77-89bb-44cf-af7a-01551da7be6a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/60362
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleWhich of the criteria is more accurate ADA(IFG100) or IDF(IFG110) for the prediction of IGT 1 and IGT2 at high risk group? The RISK Study Results III
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume50
dc.contributor.firstauthorID134204


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record